Takeda Won't Commit To Cover Eli Lilly For $9B Verdict

Takeda Pharmaceutical Co. Ltd. isn’t conceding that it needs to pay Eli Lilly & Co.’s piece of a $9 billion verdict against the two companies for allegedly hiding the cancer risks of the diabetes drug Actos, the Japan-based drugmaker said ...read more

  • Tags: